(In the early 2000s, five children who participated in a retrovirus -
based gene therapy trial for severe combined immunodeficiency developed leukemia.)
Not exact matches
He and his lab, for example, along with the company Neurologix
based in Fort Lee, N.J., are conducting a clinical
trial to test a similar
gene -
therapy treatment for Parkinson's disease.
AveXis, Inc., a clinical - stage
gene therapy company developing treatments for patients suffering from rare and life - threatening neurological genetic diseases, announced in July 2016 that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the treatment based on preliminary clinical results from the trial of AVXS
therapy company developing treatments for patients suffering from rare and life - threatening neurological genetic diseases, announced in July 2016 that the U.S. Food and Drug Administration (FDA) granted Breakthrough
Therapy Designation for the treatment based on preliminary clinical results from the trial of AVXS
Therapy Designation for the treatment
based on preliminary clinical results from the
trial of AVXS - 101.
Boston Children's Hospital has offered non-exclusive licenses to for - profit entities on a patent developed by Orkin's laboratory regarding BCL11A, a genetic switch regulating hemoglobin production that is expected to form the
basis of clinical
trials for
gene therapy and
gene editing for sickle cell disease and thalassemia.
After preclinical studies, a
gene therapy trial for SCID - X1 was initiated,
based on the use of complementary DNA containing a defective γc Moloney retrovirus — derived vector and ex vivo infection of CD34 + cells.
It is the first time that a
gene therapy based on genetically modified stem cells is tested in a multicenter, international clinical
trial that shows a reproducible and robust therapeutic effect in different centers and different countries.
In the coming months, four US clinics will recruit people with HIV to a
trial of a
therapy based on
gene editing.
The present research provides a theoretical backbone for
gene introduction research previously conducted by
trial - and - error, and is expected to contribute to the elucidation of the molecular
basis of DNA medicines and
gene therapy, and to make them more efficient.
The proposed
gene therapy is
based on the success of small human
trials of killer T - cells (Chimeric Antigen Receptor [CAR] T - cell
therapy).
Since the initial Michigan
trial, the liposomal transport system — developed by researchers at Vical, a San Diego -
based biopharmaceutical company interested in
gene therapy — has been altered in ways that are expected to make it safer, more effective and easier to administer.
Doudna believes a clinical
trial of CRISPR -
based gene therapy could begin in less than a decade.